We are live on ! Find out more

Cardlytics

CDLX

Market cap $25.2M

4.28 USD

0.00

0%

At close Updated Aug 25, 4:00 PM EDT

Pre-market

After hours

4.27

-0.01

0.23%

1 day

0%

5 days

4.39%

1 month

14.44%

3 months

-40.64%

6 months

-51.47%

Year to date

-61.79%

1 year

-60.73%

5 years

-99.51%

10 years

-96.8%

About: Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

Employees: 224

Communication Services Advertising Agencies

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026. "The second quarter shows that our execution is translating directly into results. We were within our guidance across all key metrics, with margins improving every single month of the quarter,” said Amit Gupta, CEO of Cardlytics. “We added new advertiser relationships and deepened our partnerships with existing financial insti.

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). The restricted stock units shall v.

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For a.

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardlytics Appoints Chris Cheng as Chief Legal Officer

ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. Cheng brings more than 20 years of legal leadership experience at high-growth technology companies, with deep expertise supporting public companies and partnering with executive teams during periods of transformation. With senior legal experience.

Cardlytics Appoints Chris Cheng as Chief Legal Officer

Cardlytics to Report Second Quarter 2026 Results on August 5

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close. Conference Call Details: When: August 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the.

Cardlytics to Report Second Quarter 2026 Results on August 5

Cardlytics, Inc. (CDLX) Q1 2026 Earnings Call Transcript

Cardlytics, Inc. (CDLX) Q1 2026 Earnings Call Transcript

Cardlytics, Inc. (CDLX) Q1 2026 Earnings Call Transcript

Cardlytics First Quarter 2026 Financial Results Driven By Strong Operational Performance

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a commerce media platform, today announced financial results for the first quarter ended March 31, 2026. "The first quarter of 2026 marks a definitive shift from stabilization to execution. By exceeding the midpoint of our guidance range across all key metrics, we have demonstrated that our leaner, more disciplined operating model is delivering real results," said Amit Gupta, CEO of Cardlytics. "While we navigated the anticipated shift.

Cardlytics First Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 272,000 restricted stock units of Cardlytics to six newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). Fo.

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CORRECTING and REPLACING Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release

ATLANTA--(BUSINESS WIRE)--Q126 earnings release.

CORRECTING and REPLACING Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release

See News Rankings

Price charts implemented using Lightweight Charts™